AstraZeneca PLC (AZN)
NASDAQ: AZN · Real-Time Price · USD
67.61
+0.31 (0.46%)
May 9, 2025, 4:00 PM - Market closed
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| Oncology | 20.28B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology Growth | 18.26% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals: CVRM | 12.45B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals: CVRM Growth | 17.60% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals: R&I | 7.42B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals: R&I Growth | 21.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Medicines | 1.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Medicines Growth | -8.67% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| COVID-19 | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| COVID-19 Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Collaboration | 3.14B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Collaboration Growth | 55.04% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals V&I | 1.06B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| BioPharmaceuticals V&I Growth | 4.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rare Disease | 8.67B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rare Disease Growth | 11.64% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Capex by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| UK Assets Acquired | 582.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| UK Assets Acquired Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Assets Acquired | 2.23B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Assets Acquired Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Assets Acquired | 3.93B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Assets Acquired Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Assets Acquired | 1.39B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Assets Acquired Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
EBIT by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| UK Operating Profit | 2.68B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| UK Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Operating Profit | 5.92B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Operating Profit | 423.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Operating Profit | 976.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Operating Profit Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
| UK Revenue | 4.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| UK Revenue Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe | 11.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rest of Europe Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas | 24.99B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| The Americas Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia | 12.64B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia, Africa & Australasia Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|